This section is here to support patients and families who use our services, people who may need to use our services in the future and anyone wanting to find out more about genomic testing in the NHS. We also have a useful section for clinicians.
Genomic medicine is the study of an individual's genetic makeup to identify the cause of their condition or predisposition. By better understanding genetic information, we can improve diagnosis, treatment and management and help improve patient health.
Our team collaborates with genomic laboratories, clinicians and researchers to deliver the benefits of genomic medicine to patients, families and healthcare professionals across North West London.

For Patients
Genetic testing may be available in a large number of specialties in our hospitals.

For Healthcare professionals
NHS England has worked to improve the Genomic Medicine Services with the aim of providing consistent and equitable access to genomic testing.

Meet the team
Our genomic medicine service is managed by a team of genomic practitioners and clinical genomic champions.
Latest news
-
Read the full story
World-first gene-editing treatment for blood disorders including sickle cell disease approved for use in the NHS
NICE has today approved a gene-editing treatment for use with NHS patients over the age of 12 with a severe form of sickle cell disease.
-
Read the full story
COVID-19 linked to increase in biomarkers for abnormal brain proteins
Researchers have uncovered a link between COVID-19 and blood markers linked to faulty proteins in the brain.
-
Read the full story
Personalising risk from COVID-19 key to protecting immunosuppressed people
New research underscores the need for ongoing COVID-19 protection for people with weakened immune systems.